Lan-Ping Xu Selected Research

Lan-Ping Xu Research Topics

Disease

61	Leukemia 10/2022 - 04/2006
52	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2022 - 04/2007
40	Residual Neoplasm 10/2022 - 07/2008
31	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 10/2008
28	Infections 01/2022 - 06/2004
25	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 01/2011
21	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 06/2004
16	Aplastic Anemia (Anemia, Hypoplastic) 12/2022 - 04/2004
15	Thrombocytopenia (Thrombopenia) 01/2022 - 08/2011
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 08/2008
11	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 12/2016
10	Bronchiolitis Obliterans Syndrome 01/2022 - 01/2010
9	Philadelphia Chromosome 11/2021 - 01/2011
8	Hematologic Diseases (Blood Diseases) 01/2022 - 08/2009
8	Neoplasms (Cancer) 01/2021 - 04/2007
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 08/2008
6	Viremia 06/2021 - 01/2007
5	Hemorrhage 01/2022 - 01/2007
5	Cytomegalovirus Infections (Inclusion Disease) 01/2022 - 06/2007
5	Hemorrhagic Cystitis 07/2018 - 01/2007
4	Pneumonia (Pneumonitis) 10/2021 - 06/2009
3	Virus Diseases (Viral Diseases) 11/2022 - 01/2014
3	Thrombotic Microangiopathies 01/2022 - 02/2018
3	Demyelinating Diseases (Demyelinating Disease) 11/2021 - 03/2013
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2020 - 12/2007
3	Wilms Tumor (Wilm's Tumor) 11/2019 - 05/2016
3	Multiple Myeloma 08/2019 - 01/2018
2	Mycoses (Diseases, Fungus) 03/2022 - 07/2017
2	Pancytopenia 01/2022 - 03/2020
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2021 - 05/2012
2	Disease Progression 01/2021 - 01/2019
2	Melanoma (Melanoma, Malignant) 11/2019 - 08/2016
2	Cytopenia 08/2019 - 01/2018
2	Hepatitis 01/2019 - 04/2008
2	Necrosis 01/2018 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 11/2017
2	Fever (Fevers) 08/2016 - 03/2012
1	Proteinuria 12/2021
1	Anemia 12/2021
1	Epstein-Barr Virus Infections 11/2021
1	Myeloid Sarcoma (Chloroma) 03/2021

Drug/Important Bio-Agent (IBA)

18	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 05/2008
12	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 04/2004
9	Inosine Triphosphate (ITP)IBA 01/2022 - 12/2016
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 05/2011
7	InterferonsIBA 01/2022 - 11/2015
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 08/2008
5	Prostaglandins FIBA 01/2022 - 10/2015
5	AntigensIBA 11/2021 - 08/2014
5	Immunoglobulin G (IgG)IBA 11/2021 - 07/2012
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 12/2015
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2017
4	SteroidsIBA 01/2021 - 01/2019
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 05/2008
4	LigandsIBA 12/2019 - 04/2007
3	Biological ProductsIBA 11/2022 - 05/2011
3	Basiliximab FDA Link 01/2022 - 01/2020
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 10/2017
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020 - 08/2008
3	HLA-B Antigens (HLA-B)IBA 01/2019 - 03/2012
3	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 01/2011
3	Methotrexate (Mexate)FDA LinkGeneric 07/2015 - 07/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2015 - 07/2008
2	erucylphosphocholineIBA 10/2022 - 01/2018
2	BilirubinIBA 01/2022 - 12/2021
2	Chimeric Antigen ReceptorsIBA 11/2021 - 12/2020
2	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 06/2009
2	AntibodiesIBA 11/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2016
2	GlucocorticoidsIBA 01/2019 - 07/2012
2	HLA-A Antigens (HLA-A)IBA 01/2019 - 01/2018
2	Methylprednisolone FDA LinkGeneric 01/2019 - 08/2011
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2018
2	Busulfan (Busulfex)FDA Link 01/2018 - 08/2008
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2018 - 01/2018
2	C-Reactive ProteinIBA 02/2017 - 08/2016
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021

Therapy/Procedure

152	Hematopoietic Stem Cell Transplantation 12/2022 - 01/2007
63	Transplantation 12/2022 - 04/2004
36	Stem Cell Transplantation 03/2022 - 06/2012
26	Therapeutics 01/2022 - 01/2007
20	Drug Therapy (Chemotherapy) 10/2022 - 12/2007
12	Haploidentical Transplantation 01/2021 - 11/2009
7	Cell Transplantation 01/2020 - 04/2006
5	Immunotherapy 05/2021 - 08/2016
4	Induction Chemotherapy 01/2021 - 01/2016
4	Aftercare (After-Treatment) 01/2021 - 05/2011
3	Salvage Therapy 01/2021 - 10/2016
3	Consolidation Chemotherapy 03/2019 - 01/2016
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2021 - 11/2020
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2017 - 02/2009
1	Homologous Transplantation 01/2022
1	Plasma Exchange 01/2022
1	Total Parenteral Nutrition 01/2021